Eric Chen expects a U.S. Injective ETF launch before 2027. 21Shares and Canary Capital both updated their SEC filings in September. Injective is expanding U.S. licensing and institutional tok
Injective CEO Eric Chen expects an Injective ETF to reach the U.S. market before 2027. Two applications already sit with the Securities and Exchange Commission. Both issuers filed amended registration statements in September, showing continued progress. The development comes as Injective expands licensing and institutional infrastructure in the United States.
According to The Block, the 21Shares Injective ETF and Canary Staked INJ ETF remain the two active proposals. 21Shares filed an amended S-1 on September 18 for its Nasdaq-listed TINJ fund. The product would hold INJ directly and leave staking decisions to the issuer.
The status of regulated institutional INJ products:$INJ ETP in Europe: Live$INJ Regulated U.S. Futures: Live$INJ 21Shares U.S. Spot ETF: Amended S-1/A with the SEC a few days agoCanary Staked $INJ U.S. ETF: Amendment No. 3 announced with an aim to stake 90% of INJ pic.twitter.com/VY4rcJubO3
— Injective (@injective) September 29, 2026
Canary Capital also updated its proposed staked fund with Amendment No. 3. The Canary product would trade on Cboe BZX under the ticker INJS. Its filing proposes holding spot INJ while staking at least 90% of U.S. institutional holdings.
Chen said the Injective ETF timeline now looks faster than he initially expected. He did not provide a specific launch date. However, he said waiting until 2027 appears too distant based on current progress.
Injective Institutional Services became an SEC-registered transfer agent in August. Chen described that registration as the first step in a wider U.S. licensing strategy. He said additional licenses remain under development.
The network also launched its Meridian upgrade on September 24 after a governance vote. Injective designed Meridian to support live tokenization, collateralization, and compliant transfers for institutional users. Chen said the upgrade could help affiliated entities handle settlement functions.
Injective is also expanding its regulatory position outside the United States. The project completed and published an INJ MiCA white paper in Europe. It is now listed in the European Securities and Markets Authority interim register.
The Injective ETF push arrives alongside broader ecosystem developments. Injective said more than 7.2 million INJ have been burned through its Community BuyBack. The network has also processed more than three billion transactions, including 42 million during the past 30 days.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. CoinCryptoNewz is not responsible for any losses incurred. Readers should do their own research before making financial decisions.<p>The post Injective ETF Could Arrive Before 2027, Says CEO Eric Chen first appeared on Coin Crypto Newz.</p>
